OncoCyte
Oncocyte Enters $29.1M Securities Purchase Agreement
The company expects the funds to be sufficient to complete development of its IVD diagnostic transplant assay program.
People in the News at NeoGenomics, Cofactor Genomics, LGC, Becton Dickinson, Exact Sciences, More
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
Oncocyte Kidney Transplant Test Receives Expanded Medicare Coverage
The test can be used to monitor kidney transplant patients with newly developed donor-specific antibodies for antibody-mediated rejection.
In Brief This Week: Oncocyte, Lucid Diagnostics, T2 Biosystems, All of Us, Myriad Genetics, More
News items for the week of Nov. 11, 2024
Oncocyte Nets $10.2M in Private Placement, Notes New Customers for Transplant Test
The company intends to use the funds for general corporate purposes as it seeks to gain customers and regulatory support for its GraftAssure transplant rejection test.
Jun 21, 2024
People in the News at Oncocyte, 10x Genomics
Jul 24, 2023
Oncocyte Initiates 1-for-20 Reverse Stock Split
Apr 13, 2023